UPMC Enterprises

UPMC Enterprises is the innovation and commercialization arm of UPMC, a $28 billion health care provider and insurer based in Pittsburgh, Pennsylvania. The firm focuses on developing and investing in technologies that address complex healthcare challenges, leveraging the expertise of over 5,000 UPMC physicians and insights from the UPMC Health Plan, which serves more than 4 million members. This collaboration enables UPMC Enterprises to identify, support, and commercialize scientific breakthroughs that lead to significant improvements in medical care and technology.

The firm's investment strategy centers on two primary areas: Translational Sciences and Digital Solutions. In Translational Sciences, UPMC Enterprises invests in and supports the development and commercialization of cutting-edge diagnostics and therapeutics. In Digital Solutions, it provides strategic, technical, and financial insights to build innovative products and launch novel technologies. This approach allows the firm to monitor emerging trends in healthcare and translate them into impactful solutions.

With a flexible investment model, UPMC Enterprises tailors the size of its investments to the specific needs of each opportunity, focusing on ventures that align with its strategic priorities. Over the past two decades, the firm has invested over $700 million in approximately 80 different ventures, demonstrating its commitment to fostering innovation in the healthcare sector. Notable portfolio companies include ALung Technologies and Prodiogo Solutions, reflecting the firm's dedication to advancing healthcare through strategic partnerships and investments.